Pan European Networks - Horizon 2020 - page 8

I S S U E S I X
H O R I Z O N 2 0 2 0 P R O J E C T S : P O R TA L
8
SOCIETAL CHALLENGES (continued)
152
PROFILE:
Amidst the greening of the maritime sector Clever Marine Services details how workshop facilities can be improved
152
PROFILE:
Skaginn explains its new process to prepare fish for super chilling while still at sea
153
ARCTIC ANALYSIS
154
Travelling to Trondheim, Portal carries the key findings of the Arctic Biodiversity Assessment alongside the thoughts of Hans Meltofte
PROFILE:
The Geological Survey of Norway explores the Arctic as Earth’s last frontier of unexplored mineral resources
156
A NEW ARCTIC
158
Portal details the views of the UN Environment Programme’s Mette Wilkie on the changing regional landscape at the Arctic Biodiversity Congress
REAL BIODIVERSITY?
160
Despite Horizon 2020’s inclusive nature, Professor Dr Eberhard Fischer of the University of Koblenz and Landau in Germany, speaks to
Portal about how botanic and biodiversity Calls seem to be left out of the EU framework programme’s R&I funding agenda. Fischer sets
out his main areas of concern and what changes he would like to see in the next work programme
INNOVATING WATER
162
Sören Bauer discusses how an EU initiative aims to drive the future of water innovation in Europe and details the barriers to new RDI
PROFILE:
ecoBETA
®
answers questions about its main products and services and how they benefit all who use them
166
PROFILE:
A research group from Universidade de Vigo explores the invertebrate response to environmental stress
168
HEALTH: DISEASE RESEARCH
169
GOOD PRACTICE, GOOD PROGRESS
Portal takes a detailed look at the Joint Action on Chronic Diseases, with comments from Teresa Chavarría at the first General Assembly
CHRONIC TEST
172
The acting chairman of the European Chronic Disease Alliance, Professor Dr Johan De Sutter, outlines for Portal the advances made in
2014 in tackling chronic diseases, the priorities for the year ahead, the significant role that Horizon 2020 can play, and calls on the EU
to approve a wide-ranging framework to address the burden of these health issues
PROFILE:
The Amsterdam Rheumatology immunology Center explains why chronic rheumatic diseases are the most severe
176
A NEW WAY
178
Didier Letourneur outlines the role of nanomedicine in tackling cardiovascular disease, as well as the results of the NanoAthero project
PROFILE:
Lund University explains how the cleaning of body tissues could be a new road to disease treatment and good health
180
DIABETES: THE CHALLENGES AHEAD
184
Diabetes is a debilitating chronic disease with major implications for health and wellbeing. In this article João Manuel Valente Nabais,
president of the International Diabetes Federation Europe, details the present challenges, the demands that diabetes is generating,
and the action required to curb this health challenge
PROHIBITING HOSPITAL INFECTIONS
186
At the ‘Promoting patient safety and quality of care’ event in Italy, Portal hears Dr Walter Zingg detail the FP7 PROHIBIT project results
TARGETING TB
190
Portal details an international research project receiving Horizon 2020 funding aimed at advancing the development of TB vaccines
PROFILE:
A University of Leuven group investigates the molecular mechanisms of bacterial antibiotic tolerance in chronic infections
191
ADDICTION
192
PROFILE:
The Pain Group works to reduce the amount of opioid overdoses using intranasal naloxone administration
MULTIPRONGED ATTACK
194
As young people become less informed about illicit drugs, Portal studies the European Commission’s research and international response
ONCOLOGY
198
OVERCOMING OVARIAN CANCER
Portal details the certification by the European Commission of a new drug from global firm AstraZeneca to tackle ovarian cancer
PROFILE:
RAIDs uses cervical cancer as a model for precision diagnostics, therapeutic precision and vaccine development
201
A ROADMAP FOR LIVER DISEASE
202
With liver diseases posing a significant challenge in Europe, Portal looks at the EASL’s launch of HEPAMAP
PROFILE:
The Institute of Virology explores the immune system and its link to metabolic syndrome and non-alcoholic fatty liver disease
203
EWING’S SARCOMA SOURCE
204
Professor Ivan Stamenkovic, of Switzerland’s Lausanne University Hospital, investigates the source of the malignant tumour Ewing’s sarcoma
SOCIETAL CHALLENGES: TRANSPORT
205
A TRANSPORT INVESTMENT PLAN
In a speech to MEPs, European Commissioner Violeta Bulc set out the benefits of the Investment Plan for Europe for the transport sector
©GMS-2010
© Studio Claerhout
1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...244
Powered by FlippingBook